Abstract
Recent studies using hypomorphic DNA methyltransferase 1 (DNMT1) alleles have suggested that strategies aiming to reduce DNA methylation may increase genomic instability and lymphomagenesis. Given our recent finding that loss of methyl-binding domain protein 2 (Mbd2) suppresses intestinal tumorigenesis, we have tested whether loss of Mbd2 increases lymphomagenesis by intercrossing Mbd2 deficient mice with p53 deficient and p53 heterozygous mice. Unlike DNMT1, loss of Mbd2 does not accelerate lymphomagenesis, arguing that MBD2 may represent a better potential therapeutic target than DNMT1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Campbell PM, Bovenzi V and Szyf M . (2004). Carcinogenesis, 25, 499–507.
Eads CA, Nickel AE and Laird PW . (2002). Cancer Res., 62, 1296–1299.
Eden A, Gaudet F, Waghmare A and Jaenisch R . (2003). Science, 300, 455.
Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H and Jaenisch R . (2003). Science, 300, 489–492.
Hendrich B, Guy J, Ramsahoye B, Wilson VA and Bird A . (2001). Genes Dev., 15, 710–723.
Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA and Jaenisch R . (1995). Cell, 81, 197–205.
Lengauer C . (2003). Science, 300, 442–443.
Li E, Bestor TH and Jaenisch R . (1992). Cell, 69, 915–926.
Sansom OJ, Berger J, Bishop SM, Hendrich B, Bird A and Clarke AR . (2003). Nat. Genet., 34, 145–147.
Sansom OJ and Clarke AR . (2000). Mutat. Res., 452, 149–162.
Toft NJ, Curtis LJ, Sansom OJ, Leitch AL, Wyllie AH, te Riele H, Arends MJ and Clarke AR . (2002). Oncogene, 21, 6299–6306.
Trinh BN, Long TI, Nickel AE, Shibata D and Laird PW . (2002). Mol. Cell. Biol., 22, 222906–222917.
Yang AS, Estecio MR, Garcia-Manero G, Kantarjian HM and Issa JP . (2003). Science, 302, 1153.
Acknowledgements
This work was supported by CR-UK and the Wales Gene Park.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sansom, O., Bishop, S., Bird, A. et al. MBD2 deficiency does not accelerate p53 mediated lymphomagenesis. Oncogene 24, 2430–2432 (2005). https://doi.org/10.1038/sj.onc.1208166
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208166
Keywords
This article is cited by
-
Mechanisms of Disease: methyl-binding domain proteins as potential therapeutic targets in cancer
Nature Clinical Practice Oncology (2007)